These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 8254719)

  • 1. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.
    Duan L; Ozaki I; Oakes JW; Taylor JP; Khalili K; Pomerantz RJ
    J Virol; 1994 Jul; 68(7):4302-13. PubMed ID: 8207805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
    Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
    Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.
    Zeichner SL; Kim JY; Alwine JC
    J Virol; 1991 May; 65(5):2436-44. PubMed ID: 2016766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.
    Wang J; Jones C; Norcross M; Bohnlein E; Razzaque A
    J Virol; 1994 Mar; 68(3):1706-13. PubMed ID: 8107231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat.
    Wang L; Mukherjee S; Jia F; Narayan O; Zhao LJ
    J Biol Chem; 1995 Oct; 270(43):25564-9. PubMed ID: 7592727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of HIV-1 gene expression by NF-IL6.
    Tesmer VM; Bina M
    J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
    Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
    J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements.
    Desai-Yajnik V; Samuels HH
    Mol Cell Biol; 1993 Aug; 13(8):5057-69. PubMed ID: 8393143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
    Gómez-Gonzalo M; Carretero M; Rullas J; Lara-Pezzi E; Aramburu J; Berkhout B; Alcamí J; López-Cabrera M
    J Biol Chem; 2001 Sep; 276(38):35435-43. PubMed ID: 11457829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
    Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
    AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat.
    Gualberto A; Baldwin AS
    J Biol Chem; 1995 Aug; 270(34):19680-3. PubMed ID: 7649977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.